Back
BridgeBio Pharma Stock Price Chart
Sponsored
BBIO
Sponsored
Buy a stock when it crosses this line on the chart
Here's the line to follow.
Sell
35
BBIO
BridgeBio Pharma
Last Price:
24.98
Seasonality Move:
12.97%
7 Day Trial
ALL ACCESS PASS
$
7
What's Nvidia doing next??
Click here now to learn more about Nvidia's next AI move.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BBIO is experiencing slight selling pressure.
BridgeBio Pharma Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 24.46 | Buy |
20-day SMA: | 26.4 | Sell |
50-day SMA: | 27.27 | Sell |
200-day SMA: | 30.19 | Sell |
8-day EMA: | 25.17 | Sell |
20-day EMA: | 26.06 | Sell |
50-day EMA: | 27.21 | Sell |
200-day EMA: | 28.15 | Sell |
BridgeBio Pharma Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.88 | Sell |
Relative Strength Index (14 RSI): | 42.26 | Sell |
Chaikin Money Flow: | -250761 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (25 - 28.48) | Sell |
Bollinger Bands (100): | (25.57 - 32.05) | Sell |
BridgeBio Pharma Technical Analysis
Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | Jul 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
20 | 21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for BridgeBio Pharma Stock
Is BridgeBio Pharma Stock a Buy?
- BridgeBio Pharma share price is 25.00 while BBIO 8-day simple moving average is 24.46, which is a Buy signal.
- The stock price of BBIO is 25.00 while BridgeBio Pharma 20-day SMA is 26.40, which makes it a Sell.
- BridgeBio Pharma 50-day simple moving average is 27.27 while BBIO share price is 25.00, making it a Sell technically.
- BBIO stock price is 25.00 and BridgeBio Pharma 200-day simple moving average is 30.19, creating a Sell signal.
BBIO Technical Analysis vs Fundamental Analysis
Sell
35
BridgeBio Pharma (BBIO)
is a Sell
Is BridgeBio Pharma a Buy or a Sell?
-
BridgeBio Pharma stock is rated a Sell
The current BridgeBio Pharma [BBIO] share price is $25.00. The Score for BBIO is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
BridgeBio Pharma Stock Info
Market Cap:
4.68B
Price in USD:
25.00
Share Volume:
1.02M
BridgeBio Pharma 52-Week Range
52-Week High:
44.32
52-Week Low:
16.61
Sell
35
BridgeBio Pharma (BBIO)
is a Sell
BridgeBio Pharma Share Price Forecast
-
What is the BridgeBio Pharma stock price today?
The BridgeBio Pharma stock price is 25.00 USD today. -
Will BBIO stock go up or go down?
BridgeBio Pharma> share price is forecast to RISE/FALL based on technical indicators -
Is BridgeBio Pharma overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, BridgeBio Pharma is overvalued.
Is BridgeBio Pharma Stock a Buy?
- BridgeBio Pharma share price is 25.00 while BBIO 8-day exponential moving average is 25.17, which is a Sell signal.
- The stock price of BBIO is 25.00 while BridgeBio Pharma 20-day EMA is 26.06, which makes it a Sell.
- BridgeBio Pharma 50-day exponential moving average is 27.21 while BBIO share price is 25.00, making it a Sell technically.
- BBIO stock price is 25.00 and BridgeBio Pharma 200-day simple moving average is 28.15, creating a Sell signal.
Fundamental Analysis of BridgeBio Pharma
Is BridgeBio Pharma a good investment?
- Analysts estimate an earnings increase this quarter of $0.09 per share, an increase next quarter of $0.30 per share, an increase this year of $2.47 per share, and a decrease next year of $2.17 per share.
Technical Analysis of BridgeBio Pharma
Should I short BridgeBio Pharma stock?
- BBIO Moving Average Covergence Divergence (MACD) indicator is -0.88, suggesting BridgeBio Pharma is a Sell
- BridgeBio Pharma Relative Strength Index (RSI) is 42.26, which suggest BridgeBio Pharma is oversold
- The Bollinger Bands (25) for BridgeBio Pharma is (25 - 28.48), which suggest BridgeBio Pharma is a Sell
- The Bollinger Bands (100) for BridgeBio Pharma is (25.57 - 32.05), which suggest BridgeBio Pharma is a Sell
* BridgeBio Pharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.